Citadel Advisors LLC
- SEC CIK
- 0001423053
- Latest filing
- Sep 1, 2026
ADIL holding history
Adial Pharmaceuticals, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADIL overviewAll 13F holders of ADILFull Q2 2026 holdings
- Shares (Q2 2026)
- 29,547
- Value
- $75.6K
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 29,547 | $75.6K | <0.1% | +29,547 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −8,785−100.0% | Sold outConverted for a 1-for-25 split | Holders |
| Q4 2025 | 219,621 | $48.3K | <0.1% | +75,830+52.7% | Added | Holders |
| Q3 2025 | 143,791 | $50.8K | <0.1% | +143,791 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −54,508−100.0% | Sold out | Holders |
| Q4 2024 | 54,508 | $55.1K | <0.1% | +21,238+63.8% | Added | Holders |
| Q3 2024 | 33,270 | $33.2K | <0.1% | +8,524+34.4% | Added | Holders |
| Q2 2024 | 24,746 | $28.5K | <0.1% | +24,746 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −265,062−100.0% | Sold out | Holders |
| Q3 2022 | 265,062 | $93.0K | <0.1% | +265,062 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −20,198−100.0% | Sold out | Holders |
| Q2 2021 | 20,198 | $52.0K | <0.1% | −54,093−72.8% | Reduced | Holders |
| Q1 2021 | 74,291 | $180.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.